23andMe® offers two service options to choose from:
- Health + Ancestry Service
- Ancestry Service
Both services require submitting a saliva sample using our saliva collection kit that you send to our lab for analysis.
You should choose the service option that’s right for you.
- The Health + Ancestry Service includes all of the reports and tools offered in the Ancestry Service (outlined below) plus reports on carrier status*, genetic health risks*, wellness and traits. Customers who purchase the Ancestry Service will have the option to add health and trait reports later for an additional fee.
- Both service options include tools to explore how your DNA connects you to other people. For example, if you choose to participate in the DNA Relatives tool, we can compare your DNA to other 23andMe customers, find your genetic matches, and estimate how closely you are related.
|Health + Ancestry Service||Ancestry Service|
*The 23andMe PGS test uses qualitative genotyping to detect clinically relevant variants in the genomic DNA of adults from saliva collected using a collection device (Oragene·DX model OGD-500.001) for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. The relevance of each report varies based on ethnicity. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. These reports are not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication or how much of a medication you should take. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future or anything about the health of your fetus, or your newborn child's risk of developing a particular disease later in life. For Gaucher Disease Type 1, we provide a single report that includes information on both carrier status and genetic health risk. The Late-onset Alzheimer’s Disease genetic health risk report is indicated for reporting of the ε4 variant in the APOE gene and describes if a person has a variant associated with an increased risk of developing late-onset Alzheimer’s disease. The ε4 variant included in this report is found and has been studied in many ethnicities. Detailed risk estimates have been studied the most in people of European descent. The Parkinson’s Disease genetic health risk report (i) is indicated for reporting of the G2019S variant in the LRRK2 gene, and the N370S variant in the GBA gene, (ii) describes if a person has variants associated with an increased risk of developing Parkinson’s disease, and (iii) is most relevant for people of European, Ashkenazi Jewish, and North African Berber descent.
**This data has undergone a general quality review however only a subset of markers have been individually validated for accuracy. The data from 23andMe's Browse Raw Data feature is suitable only for research, educational, and informational use and not for medical, diagnostic or other use.